arrow
B

Brenda Crabtree-Ramírez

instituto nacional de ciencias médicas y nutricion salvador zubiran
H指数:28
被引数:3,040

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictors of Liver Steatosis Progression Among People Living With HIV in Low- and Middle-Income Countries: A Multicentre Longitudinal Study

低中收入国家中人类免疫缺陷病毒感染者肝脂肪变进展的预测因素:一项多中心纵向研究

2026-09-300
OAAI
Penicillin or Ceftriaxone for Neurosyphilis in People With HIV: A Retrospective, Propensity Score–Matched Multicenter Study in Mexico

青霉素或头孢曲松治疗HIV感染者神经梅毒:一项在墨西哥进行的回顾性、倾向性评分匹配的多中心研究

2026-07-130
OA
Incidence and outcomes of anal and cervical cancer among adults with HIV in Latin America: a retrospective cohort study

拉丁美洲HIV感染者中肛管癌和宫颈癌的发病情况及结局:一项回顾性队列研究

2025-10-110
OAAI
Feasibility of an ADAPTive intervention to improve food security and Maternal-Child Health (ADAPT-MCH): Protocol for a pilot sequential multiple assignment randomized trial

适应性干预改善粮食安全与母婴健康(ADAPT-MCH)的可行性:一项序贯多重分配随机试验的方案

2025-09-010
OAAI
Temporal Trends in Tuberculosis and Time from Enrollment in Care to Antiretroviral Therapy Initiation: A Multi-country Cohort Study from Latin America

结核病的流行趋势与从护理登记到抗逆转录病毒治疗启动的时间:一项来自拉丁美洲的多国队列研究

2025-07-110
OAAI
HIV Care Continuum Outcomes Among Adolescents and Young Adults Living With HIV in Latin America and the Caribbean: Association With Depression and Substance Use

Machado, D.M.; Duda, S.N.; Celia de Menezes Succi, R.; Kim, A.; Ranadive, P.; Rouzier, V.; Crabtree-Ramirez, B.; Luque, M.T.; Mejia, F.; Rodriguez, F.; 等. 拉丁美洲和加勒比地区生活着HIV的青少年和青年患者的HIV治疗连续体结局:与抑郁和物质使用的关系。Open Forum Infect. Dis. 2025, 12, ofaf353. [Google Scholar] [CrossRef]

2025-07-010
PRE
Comorbidities and HIV-related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low- and middle-income countries: a cross-sectional study

与低收入和中收入国家生活着HIV的老年人心理健康症状和不健康物质使用相关的合并症和HIV相关因素:一项横断面研究

2025-03-050
OAAI
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel
2025-02-181
PRE
Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics
AIDS
IF3.1
2024-09-260
PRE
Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study

在3期BRIGHTE研究中,接受fostemsavir长达5年的重度治疗经验丰富的成年人的长期安全性和免疫恢复的影响

2024-05-281
OAAI
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care
2023-05-0131
OAAI